Showing 4371-4380 of 7364 results for "".
- CeraVe Shares Real Stories of Four Nurses with the Return of Heroes Behind the Maskshttps://practicaldermatology.com/news/cerave-shares-real-stories-of-four-nurses-with-the-return-heroes-behind-the-masks/2461186/In honor of National Nurses Week, CeraVe reinforces its commitment to the nursing community with the premiere of
- New Survey Reveals Negative Impact of Psoriasis on Mental Healthhttps://practicaldermatology.com/news/new-survey-reveals-negative-impact-of-psoriasis-on-mental-health/2461159/Arcutis Biotherapeutics, Inc. recently shared findings from the Skin Insights: Uncovering Psoriasis Survey, a national survey of 507 adults 18+ diagnosed with plaque psoriasis who are on topical treatments. The online survey was conducted by The Harris Poll and was designed to reveal insight
- New GEM-3 Phase 3 Results for B-VEC Presented at 2022 AAD Annual Meetinghttps://practicaldermatology.com/news/new-gem-3-phase-3-results-for-b-vec-presented-at-2022-aad-annual-meeting/2461136/Krystal Biotech, Inc
- Meet the Winners of the BTL Cares Scholarship Programhttps://practicaldermatology.com/news/meet-the-winners-of-the-btl-cares-scholarship-program/2461092/BTL and professional basketball player Andre Drummond have selected the five winners of their first-ever scholarship program – the BTL Scholar Draft. The program awarded each of the five students a $15,000 grant towards tuition and college fees. The
- Acne Breakthrough: Fat Cells in the Skin May Help Fight Acnehttps://practicaldermatology.com/news/fat-cells-in-the-skin-may-help-fight-acne/2461080/New research suggests that fibroblasts outside of hair follicles play a larger role in acne development. Fibroblasts produce an antimicrobial peptide called cathelicidin in skin. To counter an infection within a hair follicle, the surrounding skin undergoes a process called reactiv
- Dupixent Update: Medication Shows Promise in Five Inflammatory Diseaseshttps://practicaldermatology.com/news/dupixent-update-medication-shows-promise-in-five-inflammatory-diseases/2461063/Dupixent (dupilumab) performed well across five diseases with underlying type 2 inflammation. The five diseases include eosinophilic esophagitis, chronic spontaneous urticaria, asthma, chronic rhinosinusitis with nasal polyposis, and atopic dermatitis. Additionally, positive result
- NPF Launches Multimedia Resource Center for Health Care Providers Caring for Individuals with Psoriatic Diseasehttps://practicaldermatology.com/news/npf-launches-multimedia-resource-center-for-health-care-providers-caring-for-individuals-with-psoriatic-disease/2461008/The National Psoriasis Foundation (NPF) is committed to offering innovative ways for health care providers (HCPs) to stay up-to-date on the latest news and research related to psoriatic disease. As part of its five-year strategic plan to improve health outcomes for all living with the disease, in
- Data Demonstrate Safety, Efficacy of Dupilumab for AD in Patients as Young as Six Monthshttps://practicaldermatology.com/news/data-demonstrate-safety-efficacy-of-dupilumab-for-ad-in-patients-as-young-as-six-months/2461005/Data demonstrating the safety and efficacy of Sanofi and Regeneron’s
- Meet Cutera’s truSculpt® flex+https://practicaldermatology.com/news/meet-cuteras-trusculpt-flex/2460999/Cutera is rolling out the next generation of
- St. Ives Launches Social Media Contest to Help Reduce College Students' Financial and Skin Stresshttps://practicaldermatology.com/news/st-ives-launches-social-media-contest-to-help-reduce-college-students-financial-and-skin-stress/2460961/